Accessibility Menu
NeuroOne Medical Technologies logo

NeuroOne Medical Technologies(NASDAQ) NMTC

Current Price$1.91
Market Cap$16.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-97%
5 Year-94%
1 Year-69%
1 Month-41%
NeuroOne Medical Technologies last closing stock price
MetricPriceDate
Last closeUSD 1.932026-07-22
NeuroOne Medical Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-23.11%USD 2.512026-07-15
1 month-40.62%USD 3.252026-06-22
3 month-59.37%USD 4.752026-04-23
Year to date-57.56%USD 4.552025-12-31
1 year-68.77%USD 6.182025-07-22
3 year-81.62%USD 10.502023-07-21
5 year-93.84%USD 31.322021-07-23
Since inception-97.32%USD 72.002017-08-01

NeuroOne Medical Technologies Financials at a Glance

Market Cap

$16.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$9.72M

Net Income (TTM)

-$6.64M

EPS (TTM)

-$0.83

P/E Ratio

-2.32

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$1.91

Volume

522

Open

$2.03

Previous Close

$1.93

Daily Range

$1.91 - $2.03

52-Week Range

$1.89 - $6.96

Estimated Earnings Date

Aug 13, 2026

NMTC News

featured-earnings-leadership-highlights.png

NeuroOne Q3 Revenue Jumps 105 Percent

Motley Fool Markets TeamAug 14, 2025
Foolcom-Featured.png

NeuroOne Revenue Jumps 105 Percent in Q3

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NeuroOne Medical Technologies

NeuroOne makes thin film electrodes for brain and spine procedures. Its devices help doctors treat epilepsy, Parkinson’s, and chronic pain.

Gadgets That Listen (and Zap): Products and Services

  • Evo Cortical Electrode: Records and stimulates brain tissue for up to 30 days; targets epilepsy and movement disorders. (96% of product revenue was attributable to one customer, Zimmer, for the nine months ended June 30, 2025)
  • Evo sEEG Electrode: Temporarily records and stimulates subsurface brain areas; used for epilepsy diagnosis and treatment. (During the nine months ended June 30, 2025, 96% of product revenue was via Zimmer)
  • OneRF Ablation System: Creates targeted lesions in brain tissue for neurosurgery; combines recording and ablation in one device. (During the nine months ended June 30, 2025, 96% of product revenue was via Zimmer)
  • Electrode Cable Assemblies: Connects electrodes to monitoring equipment; supports all main product lines.
  • Pipeline Products: Includes drug/gene delivery and artificial intelligence applications; not yet commercialized.

Plot Twists and Power-Ups: Growth and Expansion

  • 2023: Exclusive global distribution deal with Zimmer for Strip/Grid Products, Electrode Cable Assembly Products, and certain sEEG Products.
  • October 2024: Amended Zimmer agreement for OneRF Ablation System, with $3 million upfront payment.
  • April 2025: Filed for FDA clearance of OneRF Trigeminal Nerve Ablation System (facial pain).
  • Ongoing: Partnership with RBC Medical Innovations to develop radio frequency ablation generator.
  • April 2025: Raised $8.2 million through public equity offering to support operations and development.

Why NeuroOne Gets Noticed

NeuroOne’s thin film technology allows both brain monitoring and treatment with one device. Its exclusive distribution with Zimmer gives it global reach in neurosurgical markets. The company’s focus on integrated solutions and new applications supports its competitive position.

Five Things You Need to Know

  • Revenue was $3.0 million in Q4 2025, up 906.6% from Q4 2024.
  • Gross margin reached 56.8% for nine months ended June 2025, up from 29.5%.
  • Net loss was $2.0 million for nine months ended June 2025, improved from $9.0 million.
  • Zimmer accounted for 96% of product revenue for nine months ended June 2025.

Bottom Line

NeuroOne has shifted from development to commercial sales, with strong revenue growth and improved margins. Its reliance on a single distributor and ongoing innovation define its current business profile.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

18

CEO

David A. Rosa, MBA

Website

nmtc1.com

Headquarters

Eden Prairie, MN 55344, US

NMTC Financials

Key Financial Metrics (TTM)

Gross Margin

54.50%

Operating Margin

-72.69%

Net Income Margin

-68.34%

Return on Equity

-98.33%

Return on Capital

-57.59%

Return on Assets

-84.47%

Earnings Yield

-43.10%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.70M

Volume

522

Avg. Volume

38.88K

Financials (TTM)

Gross Profit

$5.30M

Operating Income

-$7.07M

EBITDA

-$6.38M

Operating Cash Flow

-$7.43M

Capital Expenditure

-$133.43K

Free Cash Flow

-$7.57M

Cash & ST Invst.

$2.80M

Total Debt

$206.97K

NeuroOne Medical Technologies Performance Analysis

NeuroOne Medical Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 2,120,041772.6%
20232023-09-30USD 3,407,62960.7%
20242024-09-30USD 3,453,0031.3%
20252025-09-30USD 12,097,692250.4%
NeuroOne Medical Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-3022.3%
Q42025-09-3061.6%
Q12025-12-315.5%
Q22026-03-31-17.3%
NeuroOne Medical Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD -3.75-32.8%
20232023-09-30USD -3.934.7%
20242024-09-30USD -2.76-29.7%
20252025-09-30USD -0.54-80.5%
NeuroOne Medical Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-3057.7%
Q42025-09-30-42.1%
Q12025-12-3135.5%
Q22026-03-31-47.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.39M

+72.5%

Gross Profit

$1.29M

+66.9%

Gross Margin

53.81%

N/A

Market Cap

$16.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$933.16K

N/A

Employees

18

N/A

Net Income

-$2.09M

+8.1%

EBITDA

-$2.03M

+8.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$2.80M

+112.4%

Total Debt

$206.97K

-33.5%

Accounts Receivable

$2.43M

+661.2%

Inventory

$1.87M

+1.7%

Long Term Debt

$92.36K

-55.4%

Short Term Debt

$114.61K

+9.7%

Return on Assets

-84.47%

N/A

Return on Invested Capital

-1.14%

N/A

Free Cash Flow

-$1.37M

-2205.0%

Operating Cash Flow

-$1.33M

-2266.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HYPDHyperion DeFi, Inc.
$2.69-2.54%
CTSOCytosorbents Corporation
$0.39+2.12%
ZYXIZynex, Inc.
$0.13+140.38%
YI111, Inc.
$3.95+3.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.88-0.28%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.16+0.05%
HBANHuntington Bancshares
$17.38-0.05%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$37.03+0.08%

Questions About NMTC

What is the current price of NeuroOne Medical Technologies?

NeuroOne Medical Technologies is trading at $1.91 per share.

What is the 52-week range for NeuroOne Medical Technologies?

Over the past 52 weeks, NeuroOne Medical Technologies has traded between $1.89 and $6.96.

How much debt does NeuroOne Medical Technologies have?

As of the most recent reporting period, NeuroOne Medical Technologies reported total debt of $206.97K.

How much cash does NeuroOne Medical Technologies have on hand?

NeuroOne Medical Technologies reported $2.80M in cash and cash equivalents in its most recent financial results.

What is NeuroOne Medical Technologies’s dividend yield?

NeuroOne Medical Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services